KOR

e-Article

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase
Document Type
Article
Source
In Journal of Translational Autoimmunity December 2023 7
Subject
Language
ISSN
2589-9090